Kaopectate (U.S. Rights)

Kaopectate (U.S. Rights) Overview

Status Acquired/​Merged
Latest Deal Type Buyout/​LBO
Financing Rounds 1

Kaopectate (U.S. Rights) General Information

Description

Brand rights of a pharmaceutical product portfolio in the United States. The brand develops capsules & liquids for the treatment of diarrhea, indigestion and nausea.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Primary Office
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Kaopectate (U.S. Rights) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Kaopectate (U.S. Rights)‘s full profile, request access.

Request a free trial

Kaopectate (U.S. Rights) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Kaopectate (U.S. Rights)‘s full profile, request access.

Request a free trial